PDF presentation for Zhejiang Huahai Pharmaceutical Co., Ltd

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry...
Zhejiang Huahai Pharmaceuticals Co., Ltd.was initially founded in 1989, and the company's stock was successfully listed in Shanghai Stock Exchange in March, 2003. Huahai Pharmaceuticals, a large scaled modern pharmaceutical group that integrates fomulations, APIs(Active Pharmaceutical Ingredients) and intermediates, is developing both domestic and international markets, and performing parallel development of science, industry and commerce. With a total asset of 1,900 million yuan, the company has 11branches (subsidiaries) in the United States, Shanghai, Hangzhou, and Linhai.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Xunqiao, Linhai, Zhejiang 317024
Telephone
Telephone
+86-576-85016116
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

CPhI Worldwide, Milan

CPhI Worldwide, Milan

Not Confirmed

envelop Contact Supplier

CPhI Worldwide, Milan

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
“We’re unlocking life-changing potential in complex molecules, without sacrificing time to market”
This week, SpeakPharma interviews Mike Riley, CEO of Veranova, a leading contract development and manufacturing organization (CDMO) confidently mastering complex APIs as it marks its second year as an independent company. Riley discusses Veranova’s key achievements, including a US$ 30 million investment in their Devens, Massachusetts (US) site to expand capabilities in antibody-drug conjugates (ADCs) and highly potent APIs (HPAPIs), and how it is navigating the increasing complexity of molecules. 🔑 HIGHLIGHTS// Veranova’s key achievements / navigating the increasing complexity of molecules Veranova is celebrating its second year as a stand-alone company. Can you share Veranova’s key milestones and achievements in its first two years? We have achieved incredible milestones over the last two years, thanks to the dedication and hard work of our team. Our first 12 months focused on establishing ourselves as an independent CDMO by building on the 50 years of expertise that we brought with us. In addition, we expanded our capabilities and applied a more agile approach available to us as a company singularly focused on life sciences. This has allowed us to move into our second year with clear and strategic goals for generating growth in our sites, people, capabilities, and offerings. Since being appointed as CEO in May 2023, I’ve had the pleasure of witnessing some exciting growth milestones of my own. Most recently, we announced an estimated US$ 30 million investment in our Devens, Massachusetts, site. This expansion will allow us to build upon existing development and manufacturing capabilities in ADCs and HPAPIs that will address the growing demand for strong US-based capacity in these key drug modalities. We also appointed our Advisory Board, thereby bolstering Veranova’s in-house expertise. Made up of four distinguished leaders in pharma and biopharma – including Dr. Carolyn Bertozzi, the 2022 Nobel Laureate in Chemistry – the Board has provided thought-leadership, guidance and expertise as we develop and execute our strategic growth and ideas. We were also proud to be recognized as one of the Society of Chemical Manufacturers and Affiliates’ 12 companies for industry-leading safety programs in 2023 and as a part of the Medicine Maker’s Power List in 2024. 🔑 HIGHLIGHTS// US$ 30 million investment in our Devens, Massachusetts, site / appointed our Advisory Board Molecules are becoming increasingly complex. Can you elaborate on how Veranova’s current capabilities are strategically designed to address this trend in the coming years? The pharmaceutical pipeline is witnessing an increasing number of complex and highly potent molecules. This trend is driven by the demand for more targeted, patient-centric therapeutics and the focus on innovative modalities such as ADCs and other bioconjugates. At Veranova, our expertise, world-class facilities, and scientific excellence enable us to provide our customers with the clarity and solutions needed to manage this development and manufacturing complexity and ultimately deliver the required treatments to customers and patients. Our people are key to this approach. We have an expert team ready to collaborate with customers at any point, from early development through large-scale commercial production. Our services include world-leading crystallization development, process development, and specialized manufacturing expertise for complex synthetic molecules, including those requiring chromatography capabilities. In many cases, we can provide all these under one roof. Our service offering to our customers is also based on the foundational element of strong quality and compliance systems. We operate multiple facilities approved by the US FDA, UK’s MHRA and other regulatory authorities and are continually focused on ways to strengthen our global quality management system. Looking ahead, we are focused on continually investing in our facilities and team to meet growing complexity, as evidenced by our recent announcement of new investment in our Devens site. This investment signals our commitment to providing state-of-the-art capacity and capabilities to enable these next-generation therapies to reach patients. It is a key milestone as we advance Veranova’s broader growth strategy. 🔑 HIGHLIGHTS// provide our customers with clarity and solutions / world-leading crystallization development / expertise for complex synthetic molecules / strong quality and compliance systems How is Veranova approaching the challenge of designing and manufacturing effective linker molecules for ADCs? As a leader in complex linker-payload synthesis, Veranova is committed to unlocking the life-changing potential of ADCs without letting their complexities slow down the development of much-needed cancer therapies. ADCs are intricate, multi-component molecules that require extensive expertise and agile collaboration to overcome unique development challenges. With over a decade of experience in ADC linker-payload systems, we have developed the ability to anticipate challenges and avoid common pitfalls. The ADC linker-payload components are complex structures that are difficult to crystallize and require specialized high-potent handling. Veranova’s differentiated combination of world-leading crystallization development capabilities, complex synthesis experience, chromatography expertise and high-potent-handling experience put us in a unique position to solve these challenges for customers and speed their products to the clinic. We prioritize getting it right the first time, minimizing change orders and ensuring high-quality results. We have developed a robust phase-appropriate strategy that is backed by state-of-the-art analytical equipment and regulatory procedures to ensure our partners can rapidly progress their ADC projects from pre-clinical to commercialization. 🔑 HIGHLIGHTS// unlocking the life-changing potential of ADCs / ensuring our partners can rapidly progress their ADC projects Can you specify how Veranova is using artificial intelligence (AI) to optimize manufacturing processes that can reduce costs and environmental footprint as well as speed up development? In May 2024, Veranova announced a partnership with Phorum.AI to leverage AI to optimize pharmaceutical manufacturing processes. This collaboration aims to enable the rapid development of processes that can drive efficiency and reduce costs while maximizing environmental sustainability. Our goal is to combine Veranova’s extensive empirical manufacturing dataset of owned APIs and drug master files with Phorum.AI’s computational chemistry engine in order to create a more powerful process-development tool for the benefit of Veranova’s and Phorum’s customers. At Veranova, we are constantly looking to employ innovative technologies and approaches to improve efficiency, accelerate time to market and reduce environmental footprint. We have the means to work with a variety of partners who have unique project requirements, without sacrificing time to market.  🔑 HIGHLIGHTS// partnership with Phorum.AI / create a more powerful process-development tool / improve efficiency, accelerate time to market and reduce environmental footprint

Impressions: 1975

https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market

#SpeakPharma With Veranova
10 Sep 2024

VLOG #PharmaReel

[Sponsored by another company]

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices
The US is in the midst of yet another, or perhaps the most, polarizing Presidential election. The two candidates have highly divergent personas, records, visions and views. That gets reflected in their starkly different visions for the healthcare system.Healthcare is the second most important issue for voters in the 2024 US elections, with only the economy ranking higher, according to the Pew Research Center.In this week’s PharmaFlow, we look at the past approaches of both the contenders — Democratic presidential nominee Kamala Harris and Republican contender Donald Trump — towards healthcare, and what the two presidencies could mean for the US healthcare industry.Both Harris and Trump have a rare point of agreement — that the US government should act on reducing high drug prices. But have they spelt out how they will make healthcare more accessible? Our analysis should give you some answers.Abortion remains a pivotal issue, may shape broader discussions on healthcareTrump takes pride in the fact that he played an important role in overturning Roe v. Wade, a ruling that protected the abortion rights of women across America. Trump did that by selecting Supreme Court justices who were instrumental in overturning it. Two and a half years after Roe v. Wade was overturned, Trump faces an electorate that largely seems to favor abortion rights — according to Pew Research, 63 percent respondents say abortion should be legal in all or most cases, while 36 percent say it should be illegal in all or most cases.Candidates’ stances on abortion access, including the regulation on medications like mifepristone, are being scrutinized by both supporters and opponents of abortion rights. In June this year, the US Supreme Court had unanimously rejected a case to restrict access to the abortion drug mifepristone. The demand for its ban had been raised by an anti-abortion group in Texas.Of late, there have been reports of Republicans trying to distance themselves from aggressive anti-abortion ideas coming from its party men and allies. Aiming to carve-out a political middle ground, Trump has said that abortion policy should be made by the states. Despite Trump’s softening of stance, abortion rights is likely to not only affect voter turnout, but also shape broader discussions on healthcare and women’s rights.Affordable Care Act: Harris to strengthen it, Trump has ‘concepts of a plan’ to replace itHarris has been all for expanding and strengthening the Affordable Care Act (ACA). She has promised to “make affordable healthcare a right, not a privilege.”Trump, on the other hand, had made attempts during his presidency to repeal and replace the ACA, arguing that it provided “lousy healthcare.” While those efforts ultimately failed in the Senate, Trump succeeded in weakening the ACA by eliminating the individual mandate penalty through the 2017 Tax Cuts and Jobs Act.In a potential second term, Trump might renew efforts to dismantle or significantly alter the ACA. Although he has not presented a comprehensive replacement plan, he said during the Presidential debate held on September 9 that he has “concepts of a plan.”Drug prices: Harris to accelerate Medicare price cuts; Trump to focus on genericsHarris has had an aggressive stance on reducing prescription drug costs. Her tie-breaking vote on the Inflation Reduction Act gave Medicare the power to negotiate lower drug prices with pharmaceutical companies.Harris has pledged to accelerate those negotiations, once she becomes President, to cover more drugs and further lower prices for Americans. She also intends to extend the US$ 35 cap on insulin and the US$ 2,000 cap on out-of-pocket spending for seniors to all Americans, not just those on Medicare.Harris plans to make permanent the Biden-Harris tax credit enhancements that have already lowered healthcare premiums by an average of about US$ 800 a year for millions of Americans. This move would ensure continued accessibility to health insurance for a broader segment of the population.However, her stance on insurance companies and Big Pharma, including her support for “march-in” rights, might face resistance from pharmaceutical companies concerned about maintaining incentives for innovation.On the issue of drug pricing, Trump’s record is mixed. While he took credit for some decreases in prescription drug prices during his presidency, his administration’s most significant regulatory changes often favored pharmaceutical companies.Trump did issue a rule setting up a path to import drugs from Canada and other countries, but this initiative has faced significant hurdles, including pushback from Canadian authorities.Trump’s stance on drug pricing for a potential second term appears to focus on increasing generic and biosimilar competition, importing drugs made in the US but sold overseas back to the US, and capping out-of-pocket insulin costs. While he has criticized Big Pharma for putting profits above people, his administration’s policies had often aligned with industry interests.Harris appears committed to drug control; Trump had cut public health fundsMental health and substance abuse are the other areas where Harris has shown strong commitment. Having prosecuted drug traffickers, she has demonstrated her commitment to curbing the opioid epidemic.In the White House, she helped direct more than US$ 150 billion to disrupt the flow of illicit drugs and delivered billions of dollars in investments to states to fund lifesaving programs. Under a Harris administration, we might see increased funding for addiction treatment programs and continued efforts to make overdose-reversal drugs like naloxone more accessible.During his presidency, Trump had significantly reduced funding for public health programs. His administration had suggested budget cuts to the Centers for Disease Control and Prevention (CDC) and other public health agencies, justifying them as measures for fiscal responsibility.Our viewGiven her record, a Harris presidency could lead to increased insurance coverage. However, it might also come with increased regulation and price controls. More aggressive drug price negotiations could pressure pharmaceutical companies’ profit margins, potentially affecting R&D budgets. Stricter vigilance on the pharmaceutical industry could lead to more litigation and regulatory challenges for drug companies. But in the long run, this might also improve public trust in drug companies and in the healthcare systems.Under a second Trump term, reduced public health funding could create challenges for community health providers and public health initiatives. An emphasis on generic competition could pressure brand-name drug manufacturers, but create opportunities for generic drug makers.

Impressions: 518

https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices

#Phispers by PHARMACOMPASS
26 Sep 2024

NEWS #PharmaBuzz

read-more
read-more
Pfizer tabs controversial Chinese firm Huahai to make Paxlovid
Pfizer tabs controversial Chinese firm Huahai to make Paxlovid

24 Aug 2022

// Kevin Dunleavy FIERCEPHARMA

https://www.fiercepharma.com/manufacturing/paxlovid-production-pfizer-partners-chinese-company-huahai-which-coming-fda-ban

Kevin Dunleavy FIERCEPHARMA
24 Aug 2022

https://www.bnnbloomberg.ca/pfizer-picks-china-firm-involved-in-drug-recall-for-covid-pill-1.1809083

BLOOMBERG
23 Aug 2022

https://www.fiercepharma.com/pharma-asia/biocon-viatris-insulin-biosimilar-astrazeneca-china-performance-huahai-fda-warning-lift

Angus Liu FIERCEPHARMA
19 Nov 2021

https://www.fiercepharma.com/manufacturing/3-years-valsartan-recall-zhejiang-huahai-china-drug-manufacturer-fda-warning-letter

Angus Liu FIERCEPHARMA
16 Nov 2021

https://www.pharmacompass.com/pdf/news/zhejiang-huahai-pharma-receives-fda-warning-letter-1637048144.pdf

FDA
11 Nov 2021

https://endpts.com/ema-fda-begin-reviewing-heartburn-medicines-for-carcinogen/

Zachary Brennan ENDPTS
17 Sep 2019

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact Zhejiang Huahai Pharmaceutical Co., Ltd and get a quotation

Zhejiang Huahai Pharmaceutical Co., Ltd is a supplier offers 109 products (APIs, Excipients or Intermediates).

Find a price of Captopril bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Enalapril Maleate bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Escitalopram Oxalate bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Lisinopril bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Nevirapine bulk with DMF, CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Irbesartan bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Levetiracetam bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Losartan Potassium bulk with DMF, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Losartan Potassium bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Amlodipine Besylate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Aripiprazole bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Benazepril Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Candesartan Cilexetil bulk with DMF, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Carvedilol bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Citalopram Hydrobromide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Clofazimine bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Clopidogrel bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Donepezil bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Duloxetine Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Etilevodopa bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Fosinopril bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Gabapentin bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Hydrochlorothiazide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Ketotifen Fumarate bulk with CEP, JDMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Lamotrigine bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Levetiracetam bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Metoprolol Succinate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Nebivolol bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Olmesartan Medoxomil bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Paroxetine Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Pioglitazone Hydrochloride bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Pregabalin bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Quetiapine Hemifumarate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Quinapril bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Ramipril bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Risperidone bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Rivaroxaban bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Rocuronium Bromide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Sitagliptin Phosphate bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Tadalafil bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Telmisartan bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Torsemide bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Valsartan bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Voriconazole bulk with DMF, CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Paroxetine Hydrochloride bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Valsartan bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Ambrisentan bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Amisulpride bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Apixaban bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Apremilast bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Azelaic Acid bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Benserazide Hydrochloride bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Brexpiprazole bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Brivaracetam bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Canagliflozin bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Cariprazine Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Carvedilol Phosphate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Dabigatran Etexilate Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Dapagliflozin Propanediol Monohydrate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Dimethyl Fumarate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Edoxaban Tosylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Efavirenz bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Elagolix Sodium bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Empagliflozin bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Entecavir bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Eprosartan Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Ethanol bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Febuxostat bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Fingolimod Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Gabapentin bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Gefitinib bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Irbesartan bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Lacosamide bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Levetiracetam bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Levetiracetam bulk offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Linagliptin bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Lisinopril bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Losartan Potassium bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Milnacipran HCl bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Mirabegron bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Nevirapine bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Nicardipine Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Olmesartan Medoxomil bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Oseltamivir Phosphate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Paliperidone bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Paroxetine Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Perindopril Erbumine bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Ranolazine bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Rivaroxaban bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Ropinirole Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Safinamide Mesylate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Silodosin bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Telmisartan bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Tenofovir Disoproxil Fumarate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Thiaproline-M-Amino Benzoic Acid Hydrochloride bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Tofacitinib Citrate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Tolvaptan bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Topiramate bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of UNII-B7XF2TD73C bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Vortioxetine Hydrobromide bulk with DMF offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Rocuronium bromide, Acetone process bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Ropinirole hydrochloride, Micronised and non-micronised bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Candesartan cilexetil, Sieving and non-sieving bulk with CEP offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Dimethyl Fumarate bulk offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Donepezil bulk offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Losartan Potassium bulk offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of ECCPA DRUG SUBSTANCE INTERMEDIATE bulk offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Paroxetine Hydrochloride bulk offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Find a price of Strontium Ranelate bulk offered by Zhejiang Huahai Pharmaceutical Co., Ltd

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty